Experienced in Neuroepithelioma

Dr. Craig E. Grossman

Radiation Oncology
University Of Pittsburgh Cancer Institute Cancer Services
2200 Memorial Dr, 
Farrell, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Neuroepithelioma
University Of Pittsburgh Cancer Institute Cancer Services
2200 Memorial Dr, 
Farrell, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Craig Grossman is a Radiation Oncologist in Farrell, Pennsylvania. Dr. Grossman is rated as an Experienced provider by MediFind in the treatment of Neuroepithelioma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Prostatectomy. Dr. Grossman is currently accepting new patients.

His clinical research consists of co-authoring 14 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in AZ
Radiation Oncology in NJ
Radiology in IL
Hospital Affiliations
Mercy Health - Defiance Hospital
Community Hospitals And Wellness Centers
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

UNIVERSITY OF PITTSBURGH CANCER INSTITUTE CANCER SERVICES
2200 Memorial Dr, Farrell, PA 16121
Other Locations
MIDWEST COMMUNITY HEALTH ASSOCIATES, INC.
433 W High St, Bryan, OH 43506

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Enrollment Status: Recruiting
Publish Date: January 14, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Hormone therapy, Prednisone
Study Phase: Phase 3
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: January 14, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
Enrollment Status: Active_not_recruiting
Publish Date: January 14, 2026
Intervention Type: Other, Radiation, Drug
Study Drug: Apalutamide
Study Phase: Phase 2
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Radiation
Study Phase: Phase 3
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Enrollment Status: Unknown
Publish Date: June 12, 2023
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Etoposide, Carboplatin
Study Phase: Phase 3
View 5 Less Clinical Trials

13 Total Publications

American Brachytherapy Society (ABS) rectoprostatic gel spacer consensus statement.
American Brachytherapy Society (ABS) rectoprostatic gel spacer consensus statement.
Journal: Brachytherapy
Published: April 18, 2025
Similar Doctors
Matthew Ballo
Distinguished in Neuroepithelioma
Dr. Matthew Ballo
Radiation Oncology
Distinguished in Neuroepithelioma
Dr. Matthew Ballo
Radiation Oncology

Hillcrest Hospital

6780 Mayfield Road, 
Mayfield Hts, OH 
 (54.4 miles away)
440-312-4500
Experience:
35+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Matthew Ballo is a Radiation Oncologist in Mayfield Hts, Ohio. Dr. Ballo has been practicing medicine for over 35 years and is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. His top areas of expertise are Anal Cancer, Astrocytoma, Glioma, and Glioblastoma.

Advanced in Neuroepithelioma
Dr. John A. Hyland
Radiation Oncology
Advanced in Neuroepithelioma
Dr. John A. Hyland
Radiation Oncology

Mercy Health Physicians Youngstown Specialty Care LLC

1044 Belmont Ave, 
Youngstown, OH 
 (11.8 miles away)
330-480-3655
Languages Spoken:
English
See accepted insurances

John Hyland is a Radiation Oncologist in Youngstown, Ohio. Dr. Hyland is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Posterior Fossa Tumor.

Ashok Ramalingam
Advanced in Neuroepithelioma
Dr. Ashok Ramalingam
Radiation Oncology
Advanced in Neuroepithelioma
Dr. Ashok Ramalingam
Radiation Oncology

Akron General

1 Akron General Avenue, 
Akron, OH 
 (56.0 miles away)
330-344-6000
Experience:
27+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashok Ramalingam is a Radiation Oncologist in Akron, Ohio. Dr. Ramalingam has been practicing medicine for over 27 years and is rated as a Distinguished provider by MediFind in the treatment of Neuroepithelioma. His top areas of expertise are Familial Prostate Cancer, Posterior Fossa Tumor, Lung Cancer, and Pleuropulmonary Blastoma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Grossman's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 50 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile